NOV 08, 2020 7:30 AM PST

Psychedelic Mushrooms Effectively Treat Major Depression

WRITTEN BY: Annie Lennon

image

Over 17 million people in the US and 300 million people worldwide are estimated to have experienced major depression. Now, researchers from Johns Hopkins University have found that two doses of psilocybin, the psychoactive ingredient in ‘magic mushrooms’, coupled with psychotherapy, can significantly reduce depressive symptoms. 

“The magnitude of the effect we saw was about four times larger than what clinical trials have shown for traditional antidepressants on the market,” says Alan Davis, assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine. 

“Because most other depression treatments take weeks or months to work and may have undesirable effects, this could be a game changer if these findings hold up in future ‘gold-standard’ placebo-controlled clinical trials.”

For the study, the researchers involved 24 people with a long-term history of depression, most of whom experienced persistent depressive symptoms for around two years prior to enrolling in the study. The average age of the participants was 39, while 16 were women, and 22 considered themselves as ‘white’. 

The treatment consisted of two psilocybin sessions lasting five hours each monitored by two clinicians taken two weeks apart between August 2017 and April 2019. Prior to the treatment and at one week and 4-week follow-ups from treatment completion, participants were assessed with a standard depression assessment tool known as the GRID-Hamilton Depression Rating Scale. 

All in all, 67% of participants showed more than a 50% reduction in depressive symptoms at a one-week follow-up. At the four-week follow-up, this number increased to 71% of participants. On top of this, at the four-week follow-up, 54% of participants no longer qualified for being depressed.

The researchers now say that they will follow the participants for another year to see how long the antidepressant effects of psilocybin-assisted psychotherapy last, and will report their results in a later publication. 

 

Sources: Neuroscience NewsNPR

 

About the Author
Other
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
NOV 29, 2022
Genetics & Genomics
Eliminating 'Toxic' RNA Molecules to Treat ALS & Dementia
Eliminating 'Toxic' RNA Molecules to Treat ALS & Dementia
Researchers have developed a way to target RNA molecules that can have a harmful result. Instead of targeting the genome ...
DEC 24, 2022
Drug Discovery & Development
New drug discovery program powered by AI for oncology indication
New drug discovery program powered by AI for oncology indication
XtalPi is a quantum-physics, AI-powered Research and Development company based in Cambridge, MA, with branches in China. ...
JAN 05, 2023
Health & Medicine
A noninvasive sleep sensor that could prevent opioid overdose in recovering patients
A noninvasive sleep sensor that could prevent opioid overdose in recovering patients
Opioid Use Disorder (OUD) is a chronic condition of opioid use that results in significant distress, dependence, relapse ...
JAN 05, 2023
Cancer
Unraveling the link between cancer and circadian rhythm
Unraveling the link between cancer and circadian rhythm
All organisms have a circadian rhythm. In plants, for example, circadian rhythm helps sense light, temperature, length o ...
JAN 06, 2023
Drug Discovery & Development
Shellfish - the new method to prevent unwanted pregnancies
Shellfish - the new method to prevent unwanted pregnancies
A sugar that is created by shellfish may be the next best way to prevent unwanted pregnancies.  According to a 2022 ...
FEB 01, 2023
Health & Medicine
Webinar: Data Integrity and Connectivity for Lab Balances
Webinar: Data Integrity and Connectivity for Lab Balances
Data integrity is one of the most important criteria for reliable laboratory results and a hot topic for regulators and ...
Loading Comments...